Pathway Investment Co.

Private Company, Headquarters Location
5099 S Division Ave., Cutlerville, MI 49548-5601, United States
(616)531-9191, (616)531-3267 fax,

Primary SIC: Security Brokers And Dealers, Primary NAICS: Securities Brokerage
Description: Finance: Stockbrokerage.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Pathway Investment Co., News and Information

Philadelphia's Network for Teaching Entrepreneurship Celebrates Expansion, Honors Visionaries and Civic Leaders at Inaugural Gala.
Investment Weekly News; 12/5/2009; 936 words; ...Safeguard Scientifics and Co-Chair of the NFTE Philadelphia...the past two years as Co-Chair of the Philadelphia...young person will find a pathway to prosperity. Since...Financial, Investing, Investment, Marketing, Network...article was prepared by Investment Weekly News editors from...

Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution Network, Says Karkus.
PR Newswire; 12/3/2009; 1149 words; ...that further material investment in the Pharma subsidiary...opportunities, regulatory pathways, the need for further...warrant further reasonable investment in order to determine...CEO G.S. Schwartz & Co. (215) 345-0919...G.S. Schwartz & Co., +1-212-725...

Stone-built homes in historic setting.(Features)
The Journal (Newcastle, England); 11/28/2009; 801 words; ...the North East and are a great investment opportunity. "Quality homes...landscaped gardens and natural stone pathways. They will be fully decorated...countryandcoastalhomesgroup.co.uk INVESTMENT OPPORTUNITY An artist's impression...

Cannasat Therapeutics Announces New Chief Executive Officer: Anthony J. Giovinazzo, M.B.A., C.Dir.
Marketwire Canada; 11/16/2009; 1450 words; ...dedication over the last 5 years as co-founder and CEO, and look...experience ranges from the investment side as the former President...collaborations will create a pathway towards the future commercialization...well as provide important new investment to develop a pipeline of additional...

CNS Protein Therapeutics Completes Name Change to Amarantus Therapeutics, Appoints New CEO Martin D. Cleary.
Heart Disease Weekly; 11/15/2009; 1160 words; ...address the apoptotic pathway associated with a wide...President, CEO & Co-founder of CardioGene...President, CEO & Co-founder of Theragen...Commissiong, Ph.D., Co-founder of Amarantus...to raise a $1 million investment as a bridge to a $15...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.